HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P B Mark Selected Research

P B Mark Research Topics

Disease

3Chronic Kidney Failure (Chronic Renal Failure)
11/2019 - 12/2004
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2008
2Fibrosis (Cirrhosis)
02/2014 - 05/2006
2Coronary Artery Disease (Coronary Atherosclerosis)
08/2008 - 01/2007
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Acute Tubulointerstitial Nephritis
11/2019
1Chronic Renal Insufficiency
11/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Critical Illness (Critically Ill)
01/2019
1Paraganglioma (Paragangliomas)
05/2015
1Hydronephrosis
11/2009
1Nephrogenic Fibrosing Dermopathy
04/2008
1Pulmonary Arterial Hypertension
04/2007
1Pulmonary Hypertension
04/2007
1Thrombosis (Thrombus)
05/2006
1Renal Insufficiency (Renal Failure)
11/2005
1Cardiomyopathies (Cardiomyopathy)
07/2005
1Hypertension (High Blood Pressure)
04/2005
1Glucose Intolerance
12/2004
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2004

Drug/Important Bio-Agent (IBA)

2CreatinineIBA
11/2019 - 01/2019
1Endothelin A Receptor AntagonistsIBA
01/2022
1Mineralocorticoid Receptor AntagonistsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1SodiumIBA
01/2022
1Proton Pump InhibitorsIBA
11/2019
1AldosteroneIBA
02/2014
1gadodiamide (Omniscan)FDA Link
04/2008
1Contrast MediaIBA
04/2008
1Brain Natriuretic Peptide (Natrecor)FDA Link
04/2007
1pro-brain natriuretic peptide (1-76)IBA
04/2007
1GadoliniumIBA
05/2006
1Arginine (L-Arginine)FDA Link
11/2005
1Performance-Enhancing SubstancesIBA
07/2005
1Antihypertensive Agents (Antihypertensives)IBA
04/2005

Therapy/Procedure

3Therapeutics
01/2022 - 01/2007
2Kidney Transplantation
08/2008 - 04/2005
1Length of Stay
01/2019
1Nephrotomy
11/2009
1Percutaneous Coronary Intervention
08/2008
1Catheters
05/2006
1Renal Dialysis (Hemodialysis)
05/2006
1Transplantation
12/2004
1Glycemic Control
12/2004